Compumedics Limited's chairman Dr David Burton introduces the company to Proactive's Andrew Scott. It's a medical device firm involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The company's announced preliminary revenues for FY21 are approximately $35.6m or 1% higher than the $35.1m achieved in FY20.
Compumedics looks ahead to new product releases and launch of MEG system
